# CMR Surgical

> Develops the Versius modular surgical-robotics platform.

## Why it is interesting

CMR is one of the few independent soft-tissue surgical robotics companies with FDA-cleared technology and meaningful international procedure volume, making it a strategic challenger to incumbent robotic-surgery platforms.

## Profile

- **Latest funding:** Strategic preferred equity (announced; subject to closing) — Approximately $400M (£300M) (October 12, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** Not publicly disclosed
- **Stage:** growth
- **Status:** private
- **Industries:** healthtech, robotics
- **Coverage:** full
- **Last updated:** 2026-10-13
- **Latest funding investors:** Stryker

## Funding history

- Strategic preferred equity (announced; subject to closing) · Approximately $400M (£300M) · October 12, 2026
  Source: https://www.stryker.com/us/en/about/news/2026/stryker-cmr-surgical-announce-strategic-alliance-advance-robotic-assisted-surgery.html

## Related articles

- https://venturecapitaltracker.com/stryker-400m-cmr-surgical-preferred-equity-buyout-option

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** October 13, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/cmr-surgical